Resultados da busca - Isabella Ogorek

  • Mostrando 1 - 3 resultados de 3
Refinar Resultados
  1. 1
    Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

    Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia por Melanie Hüttenrauch, Isabella Ogorek, Hans‐Wolfgang Klafki, Markus Otto, Christine Stadelmann, Sascha Weggen, Jens Wiltfang, Oliver Wirths

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>

    Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vi... por Abigail K. Suwala, Katharina Koch, Dayana Herrera Rios, Philippe Aretz, Constanze Uhlmann, Isabella Ogorek, Jörg Felsberg, Guido Reifenberger, Karl Köhrer, René Deenen, Hans‐Jakob Steiger, Ulf D. Kahlert, Jarek Maciaczyk

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Blood Platelets in the Progression of Alzheimer’s Disease

    Blood Platelets in the Progression of Alzheimer’s Disease por Nina Sarah Gowert, L Donner, Madhumita Chatterjee, Yvonne S. Eisele, Seyda T. Towhid, Patrick Münzer, Britta Walker, Isabella Ogorek, Oliver Borst, Maria Grandoch, Martin Schaller, Jens W. Fischer, Meinrad Gawaz, Sascha Weggen, Florian Läng, Mathias Jucker, Margitta Elvers

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: